[(2,3-dichlorophenyl)methyl](prop-2-en-1-yl)amine, 95.0%, 2g

Methyl 2-bromo-5H-pyrrolo[2,3-b]pyrazine-7-carboxylate, 98%, 5g

4,4,5,5-Tetramethyl-2-(2-nitrophenyl)-1,3,2-dioxaborolane>98.0%(GC)(T)1g

Phthalimidoacetone, 95.0%, 100g

Diethylene Glycol Monophenyl Ether>98.0%(GC)500g

Piperazine, 1-[bis(4-fluorophenyl)methyl]-4-[(2,3,4-trimethoxyphenyl)methyl]-, hydrochloride (1:2), 98%, 250mg

(2E)-1-(2,4-dichlorophenyl)-3-(3-fluorophenyl)prop-2-en-1-one, 95.0%, 10g

Fmoc-L-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid, 99.0%, 250mg

5-(Ethoxycarbonyl)-3,6-dimethylpyrazine-2-carboxylic acid, 97.0%, 100mg

2-hydrazino-4-(trifluoromethyl)-1,3-benzothiazole, 95.0%, 500mg

2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetonitrile, 95.0%, 100g

Methyl 2-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate, 95.0%, 5g

methyl (S)-(1-((4-(3-iodo-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate, 97%, 250mg